Recurrent IgA nephropathy after renal transplantation

Seminars in Nephrology

Volumn 24, Issue 3, 2004, Pages 287-291

  Floege, Jürgen ^a,b  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

CONSERVATIVE TREATMENT; DISEASE ASSOCIATION; DRUG EFFECT; DRUG MECHANISM; FOLLOW UP; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; PHENOMENOLOGY; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK; SYSTEMATIC REVIEW; TIME;

EID: 2542491354     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2004.01.008     Document Type: Article

References (35)

1. Briganti EM, Russ GR, McNeil JJ, Atkins RC, Chadban SJ: Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 347:103-109, 2002
2. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D: Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 342:605-612, 2000
3. Floege J, Feehally J: IgA nephropathy: Recent developments. J Am Soc Nephrol 11:2395-2403, 2000
4. Donadio JV, Grande JP: IgA nephropathy. N Engl J Med 347:738-748, 2002
5. Odum J, Peh CA, Clarkson AR, et al: Recurrent mesangial IgA nephritis following renal transplantation. Nephrol Dial Transplant 9:309-312, 1994
6. Berger J, Yaneva H, Nabarra B, Barbanel C: Recurrence of mesangial deposition of IgA after renal transplantation. Kidney Int 7:232-241, 1975
7. Berger J: Recurrence of IgA nephropathy in renal allografts. Am J Kidney Dis 12:371-372, 1988
8. Kessler M, Hiesse C, Hestin D, Mayeux D, Boubenider K, Charpentier B: Recurrence of immunoglobulin A nephropathy after renal transplantation in the cyclosporine era. Am J Kidney Dis 28:99-104, 1996
9. Frohnert PP, Donadio JV Jr, Velosa JA, Holley KE, Sterioff S: The fate of renal transplants in patients with IgA nephropathy. Clin Transplant 11:127-133, 1997
10. Ohmacht C, Kliem V, Burg M, et al: Recurrent immunoglobulin A nephropathy after renal transplantation: A significant contributor to graft loss. Transplantation 64:1493-1496, 1997
11. Bumgardner GL, Amend WC, Ascher NL, Vincenti FG: Single-center long-term results of renal transplantation for IgA nephropathy. Transplantation 65:1053-1060, 1998
12. Freese P, Svalander C, Norden G, Nyberg G: Clinical risk factors for recurrence of IgA nephropathy. Clin Transplant 13:313-317, 1999
13. Kim YS, Moon JI, Jeong HJ, et al: Live donor renal allograft in end-stage renal failure patients from immunoglobulin A nephropathy. Transplantation 71:233-238, 2001
14. Andresdottir MB, Hoitsma AJ, Assmann KJ, Wetzels JF: Favorable outcome of renal transplantation in patients with IgA nephropathy. Clin Nephrol 56:279-288, 2001
15. Wang AY, Lai FM, Yu AW, et al: Recurrent IgA nephropathy in renal transplant allografts. Am J Kidney Dis 38:588-596, 2001
16. Ponticelli C, Traversi L, Feliciani A, Cesana BM, Banfi G, Tarantino A: Kidney transplantation in patients with IgA mesangial glomerulonephritis. Kidney Int 60:1948-1954, 2001
17. Park SB, Joo I, Suk J, et al: IgA nephropathy in renal transplant recipients: Is it a significant cause of allograft failure? Transplant Proc 28:1540-1542, 1996
18. Streather CP, Scoble JE: Recurrent IgA nephropathy in a renal allograft presenting as crescentic glomerulonephritis [Letter]: Nephron 66:113-114, 1994
19. Coppo R, Amore A, Cirina P, et al: Characteristics of IgA and macromolecular IgA in sera from IgA nephropathy transplanted patients with and without IgAN recurrence. Contrib Nephrol 111:85-92, 1995
20. Kimata N, Tanabe K, Ishikawa N, et al: Correlation between proteinuria and prognosis of transplant IgA nephropathy, Transplant Proc 28:1537-1539, 1996
21. Briggs JD, Jones E: Recurrence of glomerulonephritis following renal transplantation. Scientific Advisory Board of the ERA-EDTA Registry. European Renal Association-European Dialysis and Transplant Association. Nephrol Dial Transplant 14:564-565, 1999
22. Lim EC, Chia D, Gjertson DW, Koka P, Terasaki PI: In vitro studies to explain high renal allograft survival in IgA nephropathy patients. Transplantation 55:996-999, 1993
23. Scolari F: Familial IgA nephropathy. J Nephrol 12:213-219, 1999
24. Schena FP, Cerullo G, Rossini M, Lanzilotta SG, D'Altri C, Manno C: Increased risk of end-stage renal disease in familial IgA nephropathy. J Am Soc Nephrol 13:453-460, 2002
25. Floege J: Evidence-based recommendations for immunosuppression in IgA-nephropathy: Handle with caution. Nephrol Dial Transplant. 18:241-245, 2003
26. Oka K, Imai E, Moriyama T, et al: A clinicopathological study of IgA nephropathy in renal transplant recipients: beneficial effect of angiotensin-converting enzyme inhibitor. Nephrol Dial Transplant 15:689-695, 2000
27. Donadio JV Jr, Grande JP, Bergstralh EJ, Dart RA, Larson TS, Spencer DC: The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. Mayo Nephrology Collaborative Group. J Am Soc Nephrol 10:1772-1777, 1999
28. Dillon JJ: Fish oil therapy for IgA nephropathy: Efficacy and interstudy variability. J Am Soc Nephrol 8:1739-1744, 1997
29. Nowack R, Birck R, van der Woude FJ: Mycophenolate mofetil for systemic vasculitis and IgA nephropathy [Letter]. Lancet 349:774, 1997
30. Ziswiler R, Steinmann-Niggli K, Kappeler A, Daniel C, Marti HP: Mycophenolic acid: A new approach to the therapy of experimental mesangial proliferative glomerulonephritis. J Am Soc Nephrol 9:2055-2066, 1998
31. Maes BD, Evenepoel P, Kuypers D, et al: A prospective placebo-controlled randomized single center study of mycophenolate mofetil treatment for IgA nephropathy: Lack of clinical efficacy after two years [Abstract]. J Am Soc Nephrol 12:114A, 2001
32. Manu MA, Tanabe K, Ishikawa N, et al: Tacrolimus rescue for resistant rejection, chronic rejection, and immunoglobulin A nephropathy of renal allografts under primary cyclosporine A immunosuppression. Transplant Proc 31:2853-2855, 1999
33. Meulders Q, Pirson Y, Cosyns JP, Squifflet JP, van Ypersele de Strihou C: Course of Henoch-Schönlein nephritis after renal transplantation: Report on ten patients and review of the literature. Transplantation 58:1179-1186, 1994
34. Haubitz M, Kliem V, Koch KM, et al: Renal transplantation for patients with autoimmune diseases: single-center experience with 42 patients. Transplantation 63:1251-1257, 1997
35. Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D: Henoch-Schönlein purpura in adults: Outcome and prognostic factors. J Am Soc Nephrol 13:1271-1278, 2002